» Articles » PMID: 32747458

Differential Modulation of Ventral Tegmental Area Circuits by the Nociceptin/Orphanin FQ System

Overview
Journal eNeuro
Specialty Neurology
Date 2020 Aug 5
PMID 32747458
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The neuropeptide nociceptin/orphanin FQ (N/OFQ) can be released by stressors and is associated with disorders of emotion regulation and reward processing. N/OFQ and its receptor, NOP, are enriched in dopaminergic pathways, and intra-ventricular agonist delivery decreases dopamine levels in the dorsal striatum, nucleus accumbens (NAc), and ventral tegmental area (VTA). We used whole-cell electrophysiology in acute rat midbrain slices to investigate synaptic actions of N/OFQ. N/OFQ was primarily inhibitory, causing outward currents in both immunocytochemically identified dopaminergic (tyrosine hydroxylase positive (TH(+))) and non-dopaminergic (TH(-)) VTA neurons; effect at 1 μm: 20 ± 4 pA. Surprisingly, this effect was mediated by augmentation of postsynaptic GABAR currents, unlike the substantia nigra pars compacta (SNc), where the N/OFQ-induced outward currents were K channel dependent. A smaller population, 17% of all VTA neurons, responded to low concentrations of N/OFQ with inward currents (10 nm: -11 ± 2 pA). Following 100 nm N/OFQ, the response to a second N/OFQ application was markedly diminished in VTA neurons (14 ± 10% of first response) but not in SNc neurons (90 ± 20% of first response). N/OFQ generated outward currents in medial prefrontal cortex (mPFC)-projecting VTA neurons, but inward currents in a subset of posterior anterior cingulate cortex (pACC)-projecting VTA neurons. While N/OFQ inhibited NAc-projecting VTA cell bodies, it had little effect on electrically or optogenetically evoked terminal dopamine release in the NAc measured with fast scan cyclic voltammetry (FSCV). These results extend our understanding of the N/OFQ system in brainstem circuits implicated in many neurobehavioral disorders.

Citing Articles

Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release.

Zhou X, Stine C, Prada P, Fusca D, Assoumou K, Dernic J Nat Commun. 2024; 15(1):5353.

PMID: 38918403 PMC: 11199706. DOI: 10.1038/s41467-024-49712-0.


Pharmacological blockage of NOP receptors decreases ventral tegmental area dopamine neuronal activity through GABA receptor-mediated mechanism.

Petrella M, Borruto A, Curti L, Domi A, Domi E, Xu L Neuropharmacology. 2024; 248:109866.

PMID: 38364970 PMC: 11094429. DOI: 10.1016/j.neuropharm.2024.109866.


Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release.

Zhou X, Stine C, Prada P, Fusca D, Assoumou K, Dernic J bioRxiv. 2023; .

PMID: 37292957 PMC: 10245933. DOI: 10.1101/2023.05.26.542102.


Molecular and Epigenetic Aspects of Opioid Receptors in Drug Addiction and Pain Management in Sport.

Mazzeo F, Meccariello R, Guatteo E Int J Mol Sci. 2023; 24(9).

PMID: 37175536 PMC: 10178540. DOI: 10.3390/ijms24097831.


Key differences in regulation of opioid receptors localized to presynaptic terminals compared to somas: Relevance for novel therapeutics.

Coutens B, Ingram S Neuropharmacology. 2022; 226:109408.

PMID: 36584882 PMC: 9898207. DOI: 10.1016/j.neuropharm.2022.109408.


References
1.
Florin S, Suaudeau C, Meunier J, Costentin J . Nociceptin stimulates locomotion and exploratory behaviour in mice. Eur J Pharmacol. 1996; 317(1):9-13. DOI: 10.1016/s0014-2999(96)00707-8. View

2.
Puig M, Antzoulatos E, Miller E . Prefrontal dopamine in associative learning and memory. Neuroscience. 2014; 282:217-29. PMC: 4364934. DOI: 10.1016/j.neuroscience.2014.09.026. View

3.
Neal Jr C, Mansour A, Reinscheid R, Nothacker H, Civelli O, Akil H . Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol. 1999; 412(4):563-605. View

4.
Margolis E, Lock H, Chefer V, Shippenberg T, Hjelmstad G, Fields H . Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A. 2006; 103(8):2938-42. PMC: 1413839. DOI: 10.1073/pnas.0511159103. View

5.
Huang S, Borgland S, Zamponi G . Dopaminergic modulation of pain signals in the medial prefrontal cortex: Challenges and perspectives. Neurosci Lett. 2018; 702:71-76. DOI: 10.1016/j.neulet.2018.11.043. View